Palladio Biosciences, Inc., A Centessa Company
Biotechnology, 5 Walnut GRV Dr, Horsham, Pennsylvania, 19044, United States, 1-10 Employees
Phone Number: +12*********
Who is PALLADIO BIOSCIENCES, INC., A CENTESSA COMPANY
Palladio Biosciences, Inc., is a Centessa company. Our first product, lixivaptan, is in Phase 3 clinical development for the treatment of autosomal polycystic kidney disease (ADPKD). ADP...
Read More
-
Headquarters: 5 Walnut GRV Dr, Horsham, Pennsylvania, 19044, United States
-
Date Founded: 2015
-
Employees: 1-10
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from PALLADIO BIOSCIENCES, INC., A CENTESSA COMPANY
Palladio Biosciences, Inc., a Centessa company Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Palladio Biosciences, Inc., a Centessa company
Answer: Palladio Biosciences, Inc., a Centessa company's headquarters are located at 5 Walnut GRV Dr, Horsham, Pennsylvania, 19044, United States
Answer: Palladio Biosciences, Inc., a Centessa company's phone number is +12*********
Answer: Palladio Biosciences, Inc., a Centessa company's official website is https://palladiobio.com
Answer: Palladio Biosciences, Inc., a Centessa company's revenue is $5 Million to $10 Million
Answer: Palladio Biosciences, Inc., a Centessa company's SIC: 2836
Answer: Palladio Biosciences, Inc., a Centessa company's NAICS: 541714
Answer: Palladio Biosciences, Inc., a Centessa company has 1-10 employees
Answer: Palladio Biosciences, Inc., a Centessa company is in Biotechnology
Answer: Palladio Biosciences, Inc., a Centessa company contact info: Phone number: +12********* Website: https://palladiobio.com
Answer: Palladio Biosciences, Inc., is a Centessa company. Our first product, lixivaptan, is in Phase 3 clinical development for the treatment of autosomal polycystic kidney disease (ADPKD). ADPKD causes numerous fluid-filled cysts to grow in both kidneys. It is a life-limiting, chronic and progressive disease. It is the 4th leading cause of kidney failure and carries significant financial and emotional burden, affecting entire families. There is no cure for PKD. We are developing lixivaptan as a safe and effective agent to be used chronically to prevent the progression of PKD.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month